<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab2">
 <label>Table 2</label>
 <caption>
  <p>Comparison of demographics and clinical characteristics of hospitalized and non-hospitalized patients of HAdV infection between 2011 and 2014 epidemics</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th rowspan="2">Variables</th>
    <th colspan="2">2011 epidemics</th>
    <th colspan="2">2014 epidemics</th>
    <th colspan="3">Significance of comparisons</th>
   </tr>
   <tr>
    <th>Non-hospitalization</th>
    <th>Hospitalization</th>
    <th>Non-hospitalization</th>
    <th>Hospitalization</th>
    <th>P value
     <sup>1</sup>
    </th>
    <th>P value
     <sup>2</sup>
    </th>
    <th>P value
     <sup>3</sup>
    </th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>Age</td>
    <td>5.0 ± 3.1</td>
    <td>4.4 ± 3.5</td>
    <td>5.1 ± 3.3</td>
    <td>4.7 ± 3.5</td>
    <td>0.045</td>
    <td>0.209</td>
    <td>0546</td>
   </tr>
   <tr>
    <td>Gender (M/F ratio)</td>
    <td>1.08</td>
    <td>1.57</td>
    <td>1.33</td>
    <td>1.63</td>
    <td>0.072</td>
    <td>0.297</td>
    <td>0.671</td>
   </tr>
   <tr>
    <td>Co-infection</td>
    <td>7 (1.6)</td>
    <td>8 (4.2)</td>
    <td>6 (1.7)</td>
    <td>16 (10.1)</td>
    <td>0.081</td>
    <td>&lt; 0.001*</td>
    <td>0.031</td>
   </tr>
   <tr>
    <td>Underlying disease</td>
    <td>29 (6.5)</td>
    <td>28 (14.8)</td>
    <td>8 (2.3)</td>
    <td>23 (14.6)</td>
    <td>0.001*</td>
    <td>&lt; 0.001*</td>
    <td>0.946</td>
   </tr>
   <tr>
    <td colspan="8">Diagnosis</td>
   </tr>
   <tr>
    <td> Acute pharyngitis/PCF</td>
    <td>350 (78.5)</td>
    <td>73 (38.6)</td>
    <td>284 (80.7)</td>
    <td>101 (63.9)</td>
    <td>&lt; 0.001</td>
    <td>&lt; 0.001</td>
    <td>&lt; 0.001</td>
   </tr>
   <tr>
    <td> Bronchiolitis/bronchopneumonia</td>
    <td>60 (13.5)</td>
    <td>74 (39.2)</td>
    <td>55 (15.6)</td>
    <td>58 (36.7)</td>
    <td>&lt; 0.001</td>
    <td>&lt; 0.001*</td>
    <td>0.640</td>
   </tr>
   <tr>
    <td> Pneumonia</td>
    <td>1 (0.2)</td>
    <td>20 (10.6)</td>
    <td>0 (0.0)</td>
    <td>8 (5.1)</td>
    <td>&lt; 0.001</td>
    <td>&lt; 0.001</td>
    <td>0.006</td>
   </tr>
   <tr>
    <td> Acute gastro-enterocolitis</td>
    <td>34 (7.6)</td>
    <td>26 (13.8)</td>
    <td>16 (4.5)</td>
    <td>14 (8.9)</td>
    <td>0.016</td>
    <td>0.055</td>
    <td>0.155</td>
   </tr>
   <tr>
    <td colspan="8">Clinical manifestation</td>
   </tr>
   <tr>
    <td> Fever</td>
    <td>378 (84.8)</td>
    <td>168 (88.9)</td>
    <td>352 (100.0)</td>
    <td>158 (100.0)</td>
    <td>0.17</td>
    <td>–</td>
    <td>&lt; 0.001*</td>
   </tr>
   <tr>
    <td> Injected throat</td>
    <td>406 (91.0)</td>
    <td>157 (83.1)</td>
    <td>344 (97.7)</td>
    <td>152 (96.2)</td>
    <td>0.004</td>
    <td>0.381</td>
    <td>&lt; 0.001*</td>
   </tr>
   <tr>
    <td> Cough</td>
    <td>259 (58.1)</td>
    <td>151 (79.9)</td>
    <td>282 (80.1)</td>
    <td>140 (88.6)</td>
    <td>&lt; 0.001*</td>
    <td>0.019</td>
    <td>0.028*</td>
   </tr>
   <tr>
    <td> Rhinorrhea</td>
    <td>229 (51.3)</td>
    <td>112 (59.3)</td>
    <td>271 (77.0)</td>
    <td>132 (83.5)</td>
    <td>0.067</td>
    <td>0.093</td>
    <td>&lt; 0.001*</td>
   </tr>
   <tr>
    <td> Conjunctivitis</td>
    <td>35 (7.8)</td>
    <td>16 (8.5)</td>
    <td>46 (13.1)</td>
    <td>23 (14.6)</td>
    <td>0.793</td>
    <td>0.649</td>
    <td>0.074</td>
   </tr>
   <tr>
    <td> Abdominal pain</td>
    <td>66 (14.8)</td>
    <td>33 (17.5)</td>
    <td>59 (16.8)</td>
    <td>30 (19.0)</td>
    <td>0.398</td>
    <td>0.540</td>
    <td>0.713</td>
   </tr>
   <tr>
    <td> Diarrhea</td>
    <td>97 (21.7)</td>
    <td>56 (29.6)</td>
    <td>43 (12.2)</td>
    <td>44 (27.8)</td>
    <td>0.034</td>
    <td>&lt; 0.001*</td>
    <td>0.715</td>
   </tr>
   <tr>
    <td> Vomiting</td>
    <td>146 (32.7)</td>
    <td>72 (38.1)</td>
    <td>75 (21.3)</td>
    <td>61 (38.6)</td>
    <td>0.193</td>
    <td>&lt; 0.001*</td>
    <td>0.922</td>
   </tr>
   <tr>
    <td colspan="8">Laboratory monitor</td>
   </tr>
   <tr>
    <td> WBC (cells/μL)</td>
    <td>5051 ± 6336</td>
    <td>12,044 ± 5983</td>
    <td>6000 ± 6683</td>
    <td>13,130 ± 5825</td>
    <td>&lt; 0.001</td>
    <td>&lt; 0.001*</td>
    <td>0.089</td>
   </tr>
   <tr>
    <td> ANC (cells/μL)</td>
    <td>14,857 ± 77,292</td>
    <td>8312 ± 5207</td>
    <td>15,095 ± 101,895</td>
    <td>9076 ± 4865</td>
    <td>0.217</td>
    <td>0.465</td>
    <td>0.163</td>
   </tr>
   <tr>
    <td> ALC (cells/μL)</td>
    <td>2138 ± 1500</td>
    <td>2624 ± 2307</td>
    <td>2456 ± 1608</td>
    <td>2670 ± 2097</td>
    <td>0.015</td>
    <td>0.286</td>
    <td>0.847</td>
   </tr>
   <tr>
    <td> CRP (mg/L)</td>
    <td>47.6 ± 33.4</td>
    <td>80.8 ± 71.5</td>
    <td>52.4 ± 39.5</td>
    <td>77.4 ± 63.3</td>
    <td>&lt; 0.001*</td>
    <td>&lt; 0.001*</td>
    <td>0.641</td>
   </tr>
   <tr>
    <td>Survival rates</td>
    <td>445 (99.8)</td>
    <td>188 (99.5)</td>
    <td>352 (100.0)</td>
    <td>158 (100.0)</td>
    <td>–</td>
    <td>–</td>
    <td>0.360</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <p>Note: M/F ratio, male to female ratio; PCF, pharyngoconjunctival fever; WBC, white blood cell counts; ANC, absolute neutrophil counts; ALC, absolute lymphocyte counts; CRP, C-reactive protein</p>
  <p>
   <sup>123</sup>, 
   <italic>p</italic>-value of comparison between non-hospitalization and hospitalization in 
   <sup>1</sup>2011 epidemics, 
   <sup>2</sup>2014 epidemics, and 
   <italic>p</italic>-value of 
   <sup>3</sup>comparison between 2011 and 2014 epidemics given hospitalization
  </p>
  <p>* 
   <italic>P</italic> &lt; 0.05
  </p>
 </table-wrap-foot>
</table-wrap>
